Citius Oncology, Inc. (CTOR)

Citius Oncology, Inc. (CTOR) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $81.2M; returns 1 day -17.2%, 1 week -24.5%, 1 year -65.3%.

Citius Oncology Inc. (CTOR) is a biotechnology company focused on developing and commercializing critical care products, including cancer treatments and supportive care. As of January 2026, the company has a market capitalization of $90.74 million. The company reported ($0.06) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.06).

Groups CTOR belongs to

CTOR financial model: income statement, cash flow and balance sheet